A Study to Find the Best Dose of Fezolinetant to Treat Hot Flashes in Women Going Through Menopause
Clinical trial NCT05034042 · COMPLETED
Trial details
- NCT number
- NCT05034042
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-17
- Primary completion
- 2022-11-11
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.